HIV-1 Molecular Biology and Pathogenesis

The following book volume has been published in January 2008; an accompanying book volume (volume 55 on basic HIV mechanisms) was released in October 2007. 

 HIV I: Molecular Biology and Pathogenesis: Clinical Applications, Volume 56, Second Edition (Advances in Pharmacology) (Advances in Pharmacology) (Hardcover)
by Kuan-Teh Jeang (Editor) containing the following 17 chapters (each of the chapters has been listed in PubMed with the indicated identification number)

1: Angeletti PC, Zhang L, Wood C.

 The viral etiology of AIDS-associated malignancies.

Adv Pharmacol. 2008;56:509-57. PMID: 18086422

 

 

2: Ahmad N.

 Molecular mechanisms of HIV-1 vertical transmission and pathogenesis in infants. Adv Pharmacol. 2008;56:453-508. PMID: 18086421

 

 

3: Schiavone M, Quinto I, Scala G.

 Perspectives for a protective HIV-1 vaccine.

Adv Pharmacol. 2008;56:423-52. PMID: 18086420

 

 4: Hoang V, Withers-Ward E, Camerini D.

 Nonprimate models of HIV-1 infection and pathogenesis.

Adv Pharmacol. 2008;56:399-422. PMID: 18086419

 

 5: Dang Q, Hirsch VM.

 Rapid disease progression to AIDS due to Simian immunodeficiency virus infection of macaques: host and viral factors.

Adv Pharmacol. 2008;56:369-98. PMID: 18086418

 

 6: Klase ZA, Van Duyne R, Kashanchi F.

 Identification of potential drug targets using genomics and proteomics: a systems approach.

Adv Pharmacol. 2008;56:327-68. PMID: 18086417

 

 7: Giacca M.

 Gene therapy to induce cellular resistance to HIV-1 infection: lessons from clinical trials.

Adv Pharmacol. 2008;56:297-325. PMID: 18086416

 

 8: Quiñones-Mateu ME, Moore-Dudley DM, Jegede O, Weber J, J Arts E.

 Viral drug resistance and fitness.

Adv Pharmacol. 2008;56:257-96. PMID: 18086415

 

 9: Turpin JA, Schito ML, Jenkins LM, Inman JK, Appella E.

 Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors.

Adv Pharmacol. 2008;56:229-56. PMID: 18086414

 

 10: Semenova EA, Marchand C, Pommier Y.

 HIV-1 integrase inhibitors: update and perspectives.

Adv Pharmacol. 2008;56:199-228. PMID: 18086413

 

 11: Mitsuya H, Maeda K, Das D, Ghosh AK.  Development of protease inhibitors and the fight with drug-resistant HIV-1 variants. Adv Pharmacol. 2008;56:169-97.PMID: 18086412

 12: Ilina T, Parniak MA.

 Inhibitors of HIV-1 reverse transcriptase.

Adv Pharmacol. 2008;56:121-67. PMID: 18086411

 

 13: Strizki J.

 Targeting HIV attachment and entry for therapy.

Adv Pharmacol. 2008;56:93-120. PMID: 18086410

 

 14: Harari A, Pantaleo G.

 HIV-1-specific immune response.

Adv Pharmacol. 2008;56:75-92. PMID: 18086409

 

 15: Murphy EM, Jimenez HR, Smith SM.

 Current clinical treatments of AIDS.

Adv Pharmacol. 2008;56:27-73. PMID: 18086408

 

 16: Takebe Y, Uenishi R, Li X.

 Global molecular epidemiology of HIV: understanding the genesis of AIDS pandemic.

Adv Pharmacol. 2008;56:1-25. PMID: 18086407

 

17: Weiss RA.

 Preface.

Adv Pharmacol. 2008;56:XV-XVII. PMID: 18086406

 

View the latest posts on the On Biology homepage

Comments

By commenting, you’re agreeing to follow our community guidelines.

Your email address will not be published. Required fields are marked *